Unlike their similar oncogenic roles in most tumors, HIF1α and HIF2α reportedly exert opposing effects on ccRCC biology, with HIF1α acting as a tumor suppressor while HIF2α acts as an oncoprotein [46, 74]. The gene discussed is EPAS1; the disease is neoplasm.